Presented by Christopher G. Willett, MD, Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
J Natl Compr Canc Netw. 2018 May;16(5S):617-619. doi: 10.6004/jnccn.2018.0037.
The NCCN Guidelines for Rectal Cancer are now more closely aligned with those for colon cancer. A new MRI-based definition of the rectum has been included and the use of MRI in staging has been elevated in importance. There is a new emphasis on neoadjuvant therapy, especially the concurrent use of chemotherapy and radiotherapy. One of the biggest changes is more acceptance of an observational approach-"watch and wait, nonoperative management"-for select patients experiencing a complete clinical response with no evidence of residual disease after neoadjuvant therapy.
NCCN 直肠癌指南现在与结肠癌指南更加紧密地结合在一起。新纳入了一种基于 MRI 的直肠定义,并且 MRI 在分期中的使用变得更加重要。现在更加重视新辅助治疗,特别是化疗和放疗的联合应用。最大的变化之一是对于在新辅助治疗后完全临床缓解且无残留疾病证据的特定患者,更多地接受观察方法(“观察和等待,非手术治疗”)。